Tolerability, safety and pharmacokinetics of ridaforolimus in combination with bicalutamide in patients with asymptomatic, metastatic castration-resistant prostate cancer (CRPC)Hielke J. Meulenbeld, Ronald de Wit, Scott T. Tagawa et al.|Cancer Chemotherapy and Pharmacology|2013Cited by 22